References
- Clumeck N, Van Laethem V, Vanhoof R, George R, Rapin M, Butzler JP. Cefotaxime therapy of serious infections with multiresistant Gram-negative bacilli. Scand J Infect Dis 1982; 14: 57.
- Clumeck N, Van Laethem Y, Gordts B, Jaspar N, Butzler JP. Use of ceftazidime in the therapy of serious infections, including those due to multiresistant organisms. Antimicrob Agents Chemother 1983; 24: 176.
- Giamarellou H, Koratzanis G, Kanellakopoulou K, Daikos GK. Epidemiological study of Enterobacter cloacae resistant to 3rd generation cephalosporins: a preliminary report. Chemioterapia 1985; 4: 43.
- Nani E, Amato G, Lavitola A, Lembo M, Covelli B. Evaluation of ofloxacin activity against recent clinical isolates. J Chemother in press.
- Lembo M, Pedicini G, Nani E, Covelli B. In vitro antibacterial activity of Norfloxacin against recent clinical isolates. Rass. Med. Sper., 1988; XXXIV: 317–325.
- Smith JT. The mode of action of 4-quinolones and possible mechanisms of resistance. J Antimicrob Chemother, 1986; 18 (Suppl. D): 21–9.
- Inoue S, Ohue T, Yamagishi J, Nakamura S, Shimizu M. Mode of incomplete cross resistance amongst pipemidic, piromidic and nalidixic acid. Antimicrob Agents Chemother, 1978; 14: 240–249.
- King A, Phillips I. The comparative in vitro activity of eight newer quinolones and nalidixic acid. J Antimicrob Chemother, 1986; 18 (suppl. D): 1–20.
- Ericcson HM, Sherris JC. Antibiotic sensitivity testing: report of an international collaborative study. Acta Pathol Microbiol Scand, 1971; 217 (suppl.): 1.
- National Committee for Clinical Laboratory Standards: Standard methods for dilution antimicrobial susceptibility tests for bacteria which grow aerobically. NCCLS, Standard PSM-7, Villanova, Pa., 1980.
- National Committee for Clinical Laboratory Standards. Subcommittee on antimicrobial susceptibility testing. Standard reference agar dilution procedure for antimicrobial susceptibility testing of anaerobic bacteria. Tentative Standard (Mll-T) PSM-11, April 1981.
- Fass RJ. In vitro activity of ciprofloxacin. Antimicrob Agents Chemother, 1983; 24 (4): 568–74.
- Zeiler HJ. Evaluation of the in vitro and in vivo activity of ciprofloxacin in comparison to other newer quinolone derivatives. Proceedings IV Mediterranean Congress, Chemioterapia, 1985; 4 (Suppl. 2): 360–2.
- Crump B, Wise R, Dent J. Pharmacokinetics and tissue penetration of ciprofloxacin. Antimicrob Chemother, 1983; 24 (5): 784–6.
- Ullman U, Giebel W, Dalhoff A, Koeppe P. Single and multiple dose pharmacokinetics of ciprofloxacin. Eur J Clin Microbiol, 1986; 5 (2): 193–6.
- Honeybourne D, Wise R, Andrews JM. Ciprofloxacin penetration into lungs. Lancet, 1987; May 2, 1040.